Share on LinkedInShare on LinkedIn

ARTICLE · 08 JANUARY 2019

Delhi High Court Clears Procedural And Jurisdictional Issues In Antitrust Inquiry By CCI

Therefore, the Court held that investigation done by DG without CCI's recording prima facie opinion against Cadila is acceptable.

IndiaAntitrust/Competition Law

Article by MM Sharma, Head Competition Law & Policy Practice, Vaish Associates, Advocates, New Delhi, India

 The Division Bench of the High Court of Delhi comprising of Justice S. Ravindra Bhatt and Justice A K Chawla, vide its landmark judgment dated 12 September 2018 has cleared some important procedural ambiguities surrounding the inquiry by the Competition Commission of India (CCI) under the Competition Act,2002 (the Act). The Hon'ble DB of the High Court while dismissing three out of four pleas appealed by Cadila Healthcare Limited ("Cadila") in a Letter Patent Appeal (LPA) against an earlier judgment dated 09 March 2018 of the Single Bench of the Delhi High Court (Justice  V Kameshwar Rao) , has held that (i) The investigation by  the Director General (DG) does not get vitiated in the absence of specific prima facie finding against a particular party by CCI under section 26(1) of the Act; (ii) CCI can hold simultaneous inquiry under section 48 of the Act

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

© 2026, Vaish Associates Advocates,
All rights reserved
Advocates, 1st & 11th Floors, Mohan Dev Building 13, Tolstoy Marg New Delhi-110001 (India).

The content of this article is intended to provide a general guide to the subject matter. Specialist professional advice should be sought about your specific circumstances. The views expressed in this article are solely of the authors of this article.

See more popular content from